Mayur Ian Somaiya
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 22SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 900117,698 held (−1%) | $30.64 | $28K | -29.6% |
| Jan 22SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 39,71277,986 held (−34%) | $31.78 | $1.3M | -32.1% |
| Jan 22SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 19,60458,382 held (−25%) | $32.38 | $635K | -33.4% |
| Jan 22SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 15,42282,744 held (−16%) | $33.25 | $513K | -35.1% |
| Jan 22SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 24,36258,382 held (−29%) | $33.80 | $823K | -36.2% |
| Jan 7SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 5,11832,882 held (−13%) | $33.25 | $170K | -35.1% |
- Sell
CFO Mayur Ian Somaiya sold $28K of NAMS at $30.64 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Mayur Ian Somaiya sold $1.3M of NAMS at $31.78 — cuts the stake by 34%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Mayur Ian Somaiya sold $635K of NAMS at $32.38 — cuts the stake by 25%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Mayur Ian Somaiya sold $513K of NAMS at $33.25 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Mayur Ian Somaiya sold $823K of NAMS at $33.80 — cuts the stake by 29%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Mayur Ian Somaiya sold $170K of NAMS at $33.25 — pre-scheduled 10b5-1 plan sale.